The FDA prevents these 20+ arthritis drugs could cause "serious side effects"
The agency reported several pain relievers sold with hidden ingredients.
Arthritis is something tens of millions of people in the United States suffer daily. For these individuals, over the counter (OTC) analgesic can make all the difference. But you may want to be more prudent in the future if you are someone who consumes this kind of drug to appease your painful joints . The Food and Drug Administration of the United States (FDA) now warns that certain remedies sold to consumers could cause "serious side effects". Read more to find out why more than 20 arthritis drugs were reported by the agency.
In relation: Blood pressure medications recalled after oxycodone found inside, the FDA warns .
The FDA warns consumers of contaminated medicines.
The ability to believe that over -the -counter medicines sold are essential for consumers. Unfortunately, "health crooks attack people with quick and easy solutions to difficult health problems" at the FDA . AE0FCC31AE342FD3A1346EBB1F342FCB
To help fight this, the agency strives to keep people informed of drug health fraud, which includes "the marketing of drug products with unproven, false or deceptive allegations concerning the ability of These products to diagnose, cure, alleviate, process or prevent diseases or conditions. "
A large part of the FDA work has been concentrated on Find contaminated medication which are already on the market. The agency said his tests A "identified products promoted for sexual improvement, weight loss, bodybuilding, arthritis / pain, or use as sleep assistance containing hidden medication ingredients".
In relation: 2 drugs recalled after a major mix: "serious adverse events", warns the FDA .
More than 20 arthritis drugs have been reported by the agency.
In new public notifications for health fraud, the FDA is Warn That he identified several contaminated arthritis drugs sold.
"Some products promoted to arthritis and pain management contain hidden ingredients and may have a significant health risk," said the agency.
For 10 years of in -depth tests, the FDA reported a total of 22 arthritis drugs. In 2013, the first arthritis medication of which the agency warned was called ortiga , which was "an unprecedented product promoted for a variety of health problems".
But in two separate warnings issued on September 29, the agency advised consumers not to buy or use Reumo Flex Or Kuka Flex Forte —Two the products which, according to them, are "promoted and sold for joint pain and arthritis".
In relation: The ozempic patient reveals "a new" atrocious "side effect .
These products can cause "serious side effects".
The 22 arthritis drugs contained active drug ingredients that were not listed on their product labels, according to the FDA. Consequently, "these products can cause potentially serious side effects and can interact with drugs or food supplements that a consumer takes," said the agency, urging consumers to be cautious.
Some of the over -the -counter drugs used hidden ingredients found in prescription and other over -the -counter drugs. For example, Reumo Flex and Kuka Flex Forte - with many of the other reported drugs - were determined to contain diclofenac, a type of non -steroidal (or NSAID) anti -inflammatory medication, according to the FDA.
"NSAIDs can cause an increased risk of cardiovascular events, such as heart attack and cerebral vascular accidents, as well as serious gastrointestinal damage, including bleeding, ulceration and deadly perforation of the stomach and intestines, "said the agency. "This hidden medication ingredient can also interact with other drugs and considerably increase the risk of undesirable events, especially when consumers use several products containing NSAIDs."
But these are not the only drugs you need to pay attention.
The FDA is unable to test all products on the market for potentially harmful hidden ingredients. In this spirit, the agency also warns that these 22 arthritis drugs may represent only "small fraction of potentially dangerous products marketed for online consumers and stores".
"It clearly emerges from the results of our decade of tests that retailers and distributors, including online markets, do not effectively prevent these types of products potentially harmful from being sold to consumers," said the FDA. "Even if a product is not included in this list, consumers should be cautious before using these types of arthritis and pain management products."
In relation: For more information, register for our daily newsletter .
